pH-Responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy

被引:89
作者
Chiang, Yi-Ting [1 ]
Lo, Chun-Liang [1 ,2 ,3 ]
机构
[1] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, BMIRC, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Biomed Engn Res Ctr, Taipei 112, Taiwan
关键词
Liposomes; Polymers; Tumor; ECM-induced targeting; Intracellular drug delivery; Cancer therapy; STERICALLY STABILIZED LIPOSOMES; IN-VIVO; POLY(ETHYLENE GLYCOL); SENSITIVE LIPOSOMES; DOXORUBICIN; PHARMACOKINETICS; BEARING; SYSTEMS; DESTABILIZATION; COMPLEXATION;
D O I
10.1016/j.biomaterials.2014.03.046
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
This study presents a tumor-extracellular matrix pH-induced targeting liposome (ECM-targeting liposomes), crosslinked from methoxy-poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide-co-histidine)-cholesterol copolymers and biotin2-polyethylene glycol crosslinkers by hydrogen bonds to overcome the defects of liposomes. In this study, ECM-targeting liposomes were completely investigated their pH-responsibility, drug releasing behaviors, anticancer efficiencies and the time-dependent organ distribution and toxic effects. Experimental results indicate that ECM-targeting liposomes showed rapid drug releasing profiles in acidic conditions. Because the ECM-targeting liposomes accumulated preferentially in tumor, the ECM-targeting liposomes exhibited exceptional anticancer activity in vivo and lower hepatic and renal toxicity. The ECM-targeting liposomes which are switched on the targeting ability in tumor ECM possess potential for future application in anticancer therapy. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5414 / 5424
页数:11
相关论文
共 36 条
[1]
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity [J].
Adlakha-Hutcheon, G ;
Bally, MB ;
Shew, CR ;
Madden, TD .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :775-779
[2]
Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[3]
Polymer-Liposome Complexes with a Functional Hydrogen-Bond Cross-Linker for Preventing Protein Adsorption and Improving Tumor Accumulation [J].
Chiang, Yi-Ting ;
Cheng, Yung-Ting ;
Lu, Chih-Yang ;
Yen, Yu-Wei ;
Yu, Lu-Yi ;
Yu, Kun-Siou ;
Lyu, Sih-Ying ;
Yang, Chieh-Yu ;
Lo, Chun-Liang .
CHEMISTRY OF MATERIALS, 2013, 25 (21) :4364-4372
[4]
LIPOSOMAL DOXORUBICIN-INDUCED TOXICITY - DEPLETION AND IMPAIRMENT OF PHAGOCYTIC-ACTIVITY OF LIVER MACROPHAGES [J].
DAEMEN, T ;
HOFSTEDE, G ;
KATE, MTT ;
BAKKERWOUDENBERG, IAJM ;
SCHERPHOF, GL .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) :716-721
[5]
Toxicity of doxorubicin entrapped within long-circulating liposomes [J].
Daemen, T ;
Regts, J ;
Meesters, M ;
TenKate, MT ;
BakkerWoudenberg, IAJM ;
Scherphof, GL .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (01) :1-9
[6]
Drummond DC, 1999, PHARMACOL REV, V51, P691
[7]
A SENSITIVE PROCEDURE FOR THE QUANTITATION OF FREE AND N-(2-HYDROXYPROPYL)METHACRYLAMIDE POLYMER-BOUND DOXORUBICIN (PK1) AND SOME OF ITS METABOLITES, 13-DIHYDRODOXORUBICIN, 13-DIHYDRODOXORUBICINONE AND DOXORUBICINONE, IN HUMAN PLASMA AND URINE BY REVERSED-PHASE HPLC WITH FLUOROMETRIC DETECTION [J].
FRAIER, D ;
FRIGERIO, E ;
PIANEZZOLA, E ;
BENEDETTI, MS ;
CASSIDY, J ;
VASEY, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (4-5) :625-633
[8]
Characterization of pH-dependent poly(acrylic acid) complexation with phospholipid vesicles [J].
Fujiwara, M ;
Grubbs, RH ;
Baldeschwieler, JD .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1997, 185 (01) :210-216
[9]
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates [J].
Gabizon, A ;
Shmeeda, H ;
Horowitz, AT ;
Zalipsky, S .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (08) :1177-1192
[10]
Gabizon A, 2003, CLIN CANCER RES, V9, P6551